NCT04141566
- Conditions
- Colorectal Neoplasms, Colostomy Stoma, Digestive System Diseases, +10 more
- Locations
-
- National Institut of Oncology, Surgical oncology department Rabat, Morocco
Clinical trial condition
Gastrointestinal Neoplasms
Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.
9,284 public trials
2,067 recruiting studies
Gastrointestinal Neoplasms trial results
NCT02182804
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +6 more
- Locations
-
Not specified
NCT03413436
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
- Locations
-
- Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Zhengzhou, Henan, China
NCT03524716
- Conditions
- Behavior, Colon Cancer, Colonic Diseases, +15 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT04526314
- Conditions
- Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +9 more
- Locations
-
- Registre de tumeurs digestives du Finistère Brest, France
NCT01928290
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
Completed
Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor
NCT01068769
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Oregon Health Sciences University Portland, Oregon, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT01634685
- Conditions
- Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Completed
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
NCT02658214
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +58 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Kashiwa, Japan
- Research Site Seoul, South Korea
- Research Site Seoul, South Korea
NCT02355262
- Conditions
- Breast Carcinoma, Breast Diseases, Breast Neoplasms, +40 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States